ABVC BioPharma Statistics
NASDAQ: ABVCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.00+0.03 (+3.09%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ABVC BioPharma by the numbers
ABVC BioPharma has a market capitalization of $26.7 million based on 26.69M shares outstanding. With trailing EPS of $-0.30, ABVC BioPharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.7% above its 50-day average and 26.6% below its 200-day average.
Average daily trading volume is 118.80K shares, or about $118,796 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABVC valuation vs. peer median
| Metric | ABVC | Peer median | Difference |
|---|---|---|---|
| Market cap | $26.69M | $28.02M | -5% |
| Avg. volume | 118.80K | 86.92K | +37% |
Peer median across 8 companies: BYSI, MCRB, KYNB, CNTX, ATOS, IGC, GRDX, RNAZ.
Valuation
- Market cap
- $26.69M
- EPS (TTM)
- $-0.30
- Shares outstanding
- 26.69M
Price and trading
- Previous close
- 0.97
- Open
- 0.9409
- Day range
- 0.94 – 1.01
- 52-week range
- 0.707 – 3.33
- 52-week change
- -68.94%
- 50-day moving average
- 0.9835
- Beta
- —
- Volume
- 52.74K
- Average volume
- 118.80K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 30, 2026
Additional statistics
- Market Cap
- 26.69M
- Forward Pe
- -2.27
- Eps
- -0.30
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.33
- Week52 Low
- 0.71
- Avg Volume
- 118.80K
- Shares Outstanding
- 26.69M
- Ma50
- 0.98
- Ma200
- 1.36
- Earnings Date
- Oct 30, 2026
- Pct From52w High
- -69.97%
- Pct From52w Low
- 41.44%